CTNI-29. CODEL: PHASE III TRIAL OF RT ALONE, RT PLUS TMZ, OR TMZ ALONE FOR NEWLY-DIAGNOSED, 1p/19q CODELETED ANAPLASTIC OLIGODENDROGLIOMA. ANALYSIS FROM THE INITIAL STUDY DESIGN. (NCCTG N0577, ALLIANCE)

BACKGROUND: The original 3-arm CODEL design included a radiotherapy (RT)-alone control arm, an RT plus temozolomide (TMZ) arm, and an exploratory TMZ-alone arm. We report the analysis involving patients treated per the initial design. METHODS: Adults (18+ years) with newly-diagnosed 1p/19q codeleted...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Jaeckle, Kurt, Ballman, Karla, van den Bent, Martin, Giannini, Caterina, Galanis, Evanthia, Brown, Paul, Jenkins, Robert, Cairncross, Gregory, Wick, Wolfgang, Weller, Michael, Aldape, Kenneth, Dixon, Jesse, Anderson, S Keith, Cerhan, Jane, Wefel, Jeffrey S, Klein, Martin, Grossman, Stuart, Schiff, David, Raizer, Jeffrey, Dhermain, Frederick, Nordstrom, Donald, Flynn, Patrick, Vogelbaum, Michael
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Clinical Trials: Non-Immunologic
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650476/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.196
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller